We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
IBM
IBM
$222B
| $7.43M | 0.12% |
+57,117
| New | +$7.45M |
|
202
Otis Worldwide
OTIS
$28B
| $7.4M | 0.12% |
96,213
-73,118
| -43% | -$5.84M |
|
203
AlTi Global
ALTI
$412M
| $7.4M | 0.12% |
749,999
| – | – |
|
204
Revvity
RVTY
$12.4B
| $7.4M | 0.12% |
42,400
| – | – |
|
|
AUS
205
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $7.37M | 0.12% |
750,000
| – | – |
|
|
KLRS
206
Kalaris Therapeutics
KLRS
$103M
| $7.34M | 0.12% |
47,265
| – | – |
|
|
KALV
207
DELISTED
KalVista Pharmaceuticals
KALV
| $7.33M | 0.12% |
497,014
+358,276
| +258% | +$5.15M |
|
|
RACB
208
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $7.32M | 0.12% |
750,000
| – | – |
|
209
Kulicke & Soffa
KLIC
$4.91B
| $7.24M | 0.12% |
+129,210
| New | +$7.13M |
|
|
MRUS
210
DELISTED
Merus
MRUS
| $7.19M | 0.12% |
271,916
+40,179
| +17% | +$1.08M |
|
|
NGM
211
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $7.18M | 0.12% |
+471,039
| New | +$7.35M |
|
|
OPTU
212
Optimum Communications Inc
OPTU
$343M
| $7.17M | 0.12% |
574,336
-677,486
| -54% | -$9.05M |
|
213
Ionis Pharmaceuticals
IONS
$9.15B
| $7.14M | 0.12% |
192,651
-218,803
| -53% | -$7.16M |
|
|
COHR
214
DELISTED
Coherent Inc
COHR
| $7.13M | 0.12% |
26,063
+4,043
| +18% | +$1.06M |
|
215
Automatic Data Processing
ADP
$108B
| $7.11M | 0.12% |
31,248
-142,679
| -82% | -$30.5M |
|
216
Vor Biopharma
VOR
$1.21B
| $6.71M | 0.11% |
55,556
| – | – |
|
217
Pacira BioSciences
PCRX
$1.09B
| $6.7M | 0.11% |
87,800
| – | – |
|
218
iHeartMedia
IHRT
$582M
| $6.68M | 0.11% |
352,855
-7,598
| -2% | -$151K |
|
|
WWE
219
DELISTED
World Wrestling Entertainment
WWE
| $6.43M | 0.1% |
+103,033
| New | +$5.69M |
|
220
Seer Inc
SEER
$122M
| $6.31M | 0.1% |
414,187
+90,007
| +28% | +$1.39M |
|
|
MGI
221
DELISTED
MoneyGram International, Inc. New
MGI
| $6.29M | 0.1% |
+595,203
| New | +$5.73M |
|
222
Fate Therapeutics
FATE
$300M
| $6.23M | 0.1% |
160,718
-38,358
| -19% | -$1.49M |
|
|
SGFY
223
DELISTED
Signify Health, Inc.
SGFY
| $6.23M | 0.1% |
343,251
+331,281
| +2,768% | +$4.75M |
|
|
LATGU
224
DELISTED
Chenghe Acquisition I Co. Unit
LATGU
| $6.03M | 0.1% |
+600,000
| New | +$6M |
|
|
STKL
225
DELISTED
SunOpta
STKL
| $6.02M | 0.1% |
1,200,081
-472,192
| -28% | -$2.49M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.